Spero Therapeutics, Inc. (SPRO)

NASDAQ: SPRO · IEX Real-Time Price · USD

1.435

+0.030 (2.14%)

At close: Apr 23, 2024, 4:00 PM

1.442

+0.007 (0.49%)

After-hours: Apr 23, 2024, 5:35 PM EDT

Spero Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015
Cash & Equivalents	76.33	109.11	112.58	85.21	29.73	34.08	87.54	10.57	5.89
Short-Term Investments	0	0	33.82	41.7	52.32	81.36	0	0	0
Cash & Cash Equivalents	76.33	109.11	146.4	126.91	82.05	115.44	87.54	10.57	5.89
Cash Growth	-30.04%	-25.47%	15.36%	54.68%	-28.93%	31.87%	728.15%	79.35%	-
Receivables	97.29	1.08	2.64	5.33	7.76	0.38	1.01	0.3	0.01
Other Current Assets	-42.41	3.38	8.83	6.91	5.61	8.4	3.5	1	0.08
Total Current Assets	131.21	113.57	157.87	139.15	95.41	124.22	92.06	11.87	5.99
Property, Plant & Equipment	4.16	5.49	7.56	8.78	7.15	2.89	1.16	1.5	0.95
Other Long-Term Assets	47.03	5.74	5.64	5.52	3.54	1.89	0.26	0.4	0.24
Total Long-Term Assets	51.18	11.23	13.2	14.31	10.69	4.79	1.42	1.9	1.19
Total Assets	182.39	124.8	171.07	153.45	106.1	129.01	93.48	13.77	7.18
Accounts Payable	1.38	0.62	1.1	1.16	4.15	3.6	3.47	1.14	1.79
Deferred Revenue	61.54	32.54	10.64	0	0	0	0	0	0
Current Debt	1.72	1.69	1.36	0.95	0.93	0	0	0	0
Other Current Liabilities	-27.49	-13.19	5.56	12.24	21.59	8.72	4.69	5.78	4.63
Total Current Liabilities	37.15	21.65	18.67	14.34	26.66	12.32	8.16	6.92	6.42
Long-Term Debt	3.83	4.96	5.97	6.89	4.62	0	0	0	0
Other Long-Term Liabilities	34.52	22.26	58.14	0.18	0.25	0.83	0.37	0.49	1.01
Total Long-Term Liabilities	38.34	27.22	64.11	7.07	4.87	0.83	0.37	0.49	1.01
Total Liabilities	75.5	48.87	82.78	21.41	31.53	13.15	8.52	7.41	7.43
Total Debt	5.54	6.65	7.34	7.84	5.55	0	0	0	0
Debt Growth	-16.61%	-9.38%	-6.42%	41.35%	-	-	-	-	-
Retained Earnings	-391.07	-413.88	-367.46	-277.71	-199.43	-138.5	-96.84	-45.44	-18.1
Comprehensive Income	0	0	-0	-0.01	0.02	-0.03	0	0	0
Shareholders' Equity	106.89	75.93	88.29	132.04	74.57	115.5	84.6	-45.44	-18.1
Net Cash / Debt	70.79	102.46	139.07	119.07	76.5	115.44	87.54	10.57	5.89
Net Cash / Debt Growth	-30.91%	-26.32%	16.80%	55.64%	-33.73%	31.87%	728.15%	79.35%	-
Net Cash Per Share	1.34	2.73	4.50	5.32	4.21	7.21	33.84	33.86	23.31
Working Capital	94.06	91.92	139.2	124.8	68.75	111.9	83.9	4.95	-0.43
Book Value Per Share	2.03	2.02	2.86	5.90	4.11	7.22	32.70	-145.56	-71.60

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).